Effectiveness: | Cardiovascular health | 1. Sources and Habitat Ginkgo (Ginkgo biloba), also known as the Maidenhair Tree after Adiantum, is a unique species of tree with no close living relatives. The ginkgo is classified in its own division , the Ginkgophyta, comprising the single class Ginkgoopsida, order Ginkgoales, family Ginkgoaceae , genus Ginkgo and is the only extrant species within this group. 2. Descriptions and Specifications of Product Content Specifications: 24.0%Flavones 6.0% lactones by HPLC CP2005 EP6.0 3. Indications and Uses Ginkgo biloba is used for cerebral insufficiency and Alzheimer's disease. It also is used for peripheral vascular insufficiency. Certificate of Analysis Ginkgo Biloba Extract 24%6% by HPLC Product Name | Ginkgo Biloba P.E. | Botanical Source | Ginkgo biloba L | Solvent Used | Ethanol & Water | Part Used | Leaves | Batch Number | 20110415 | Manufacture Date | 04.12.2011 | Batch Quantity | 1000kgs/40drums | Analysis Date | 04.15.2011 | ANALYSIS | SPECIFICATION | RESULTS | TEST METHODS | Assay | NLT24.0% Flavones NLT6.0% Lactones | 24.13% 6.05% | HPLC HPLC | Chemical Physical Control | | | | Characters/Appearance | Fine Powder | Conforms | Visual | Color | Brown-Yellow | Conforms | Visual | Odor | Characteristic | Conforms | Organoleptic | Taste | Characteristic | Conforms | Organoleptic | Mesh Size/Sieve Analysis | NLT100%Through 80 mesh | Conforms | 80 Mesh Screen | Bulk Density | 40-60g/100ml | 52g/100ml | / | Loss on drying | NMT5.0% | 2.33% | 5g/105°C/2hrs | Arsenic (As) | NMT2ppm | Conforms | AFS | Lead (Pb) | NMT2ppm | Conforms | AFS | Microbiology Control | | | | Total Plate Count | NMT1,000cfu/g | Conforms | CP2005 | Total Yeast & Mold | NMT100cfu/g | Conforms | CP2005 | E.Coli. | Negative | Conforms | CP2005 | Packing & Storage | Packed in paper-drums and two plastic-bags inside.N.W.:25kgs. I.D.35cm×H51cm Store in a well-closed container Away from moisture. | Shelf Life | Two years if sealed and store away from direct sun light. | Send your inquiry to this supplier Send Inquiry
|